Status:
COMPLETED
Study of the Effect of Dipyrone, Ibuprofen, Paracetamol and Parecoxib on the Platelet Aggregation in Analgetic Dosages
Lead Sponsor:
Ruhr University of Bochum
Collaborating Sponsors:
Pfizer
Conditions:
Platelet Aggregation
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Dipyrone is suggested to inhibit the platelet aggregation comparable to th effect of traditional analgetic substances like Ibuprofen. To verify this hypothesis the investigators conducted the study in...
Eligibility Criteria
Inclusion
- Planned traumatologic, orthopedic, visceral or plastic surgical procedures
Exclusion
- Prior intake of drugs with effect on the platelet aggregation
- Patients with diseases of the gastrointestinal systems
- Patients with cardiac or circulatory diseases
- Patients receiving corticoids
- Patients with cold or asthma
- ASA-classification \> 3
Key Trial Info
Start Date :
February 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2004
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00763997
Start Date
February 1 2004
End Date
December 1 2004
Last Update
October 1 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BG University Hospital Bergmannsheil GmbH
Bochum, Germany, 44789